MLYS Mineralys Therapeutics, Inc.
Nasdaq · SEC CIK 1933414 · EDGAR
- Bought, last 12 months
- $8.76M 1 purchases by 1 insiders
- Sold, last 12 months
- $87.64M 43 sales by 8 insiders
- Filings on record
- 159 since 2023-02-13, latest 2026-09-24 21:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Catalys Pacific Fund, LP | 10% | — | $43.35M |
| Congleton Jon | CEO, Dir | — | $14.91M |
| Rodman David Malcom | Chief Medical Off | — | $14.41M |
| Shah Rajeev M. | Dir | $8.76M | — |
| Levy Adam Scott | CFO, Sec | — | $6.16M |
| Warren Eric | Chief Commercial Off | — | $3.30M |
| Slingsby Brian Taylor | Dir, 10% | — | $3.01M |
| Gold Alexander M | Dir | — | $1.58M |
| Karydas Daphne | Dir | — | $925.6K |
| DiRocco Derek | Dir | — | — |
Transactions 166
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-16 | 2025-06-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,348 | 113.0K | +6% | +$6,856 |
| 2025-05-15 | 2025-05-14 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale | $15.29 | -11.4K | 106.7K | -10% | -$173.8K | |
| D | 2025-05-13 | 2025-05-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 118.0K | +6% | +$6,857 |
| I | 2025-04-25 | 2025-03-13 | MLYS | Slingsby Brian Taylor | Dir, 10% | P - Purchase | $13.50 | +259.3K | 8.90M | +3% | +$3.50M |
| 2025-04-15 | 2025-04-11 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $12.06 | -10.8K | 215.3K | -5% | -$129.7K | |
| 2025-04-15 | 2025-04-11 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $12.19 | -15.3K | 862.3K | -2% | -$186.7K | |
| D | 2025-04-15 | 2025-04-14 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,348 | 123.1K | +5% | +$6,856 |
| DM | 2025-04-15 | 2025-04-14 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $14.53 | -11.4K | 111.7K | -9% | -$165.2K |
| D | 2025-04-03 | 2025-04-01 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +1,606 | 172.5K | +0.9% | +$1,734 |
| DM | 2025-04-03 | 2025-04-01 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.76 | -55.8K | 116.7K | -32% | -$879.1K |
| I | 2025-03-17 | 2025-03-13 | MLYS | AKKARAJU SRINIVAS | Dir | P - Purchase | $13.50 | +600.0K | 5.67M | +12% | +$8.10M |
| I | 2025-03-17 | 2025-03-13 | MLYS | RA Capital Nexus Fund III, L.P. | Dir | P - Purchase | $13.50 | +1.30M | 4.28M | +43% | +$17.50M |
| I | 2025-03-17 | 2025-03-13 | MLYS | Samsara BioCapital, L.P. | 10% | P - Purchase | $13.50 | +600.0K | 5.67M | +12% | +$8.10M |
| D | 2025-03-13 | 2025-03-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 170.9K | +4% | +$6,857 |
| D | 2025-02-13 | 2025-02-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,348 | 164.5K | +4% | +$6,856 |
| DM | 2025-01-15 | 2025-01-13 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 158.2K | +8% | +$9,567 |
| M | 2025-01-15 | 2025-01-13 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $9.10 | -10.8K | 226.1K | -5% | -$97.8K |
| 2025-01-15 | 2025-01-13 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $9.06 | -18.3K | 877.6K | -2% | -$166.1K | |
| D | 2024-12-13 | 2024-12-11 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +5,017 | 146.0K | +4% | +$2,709 |
| DM | 2024-11-12 | 2024-11-11 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8102 | +10.0K | 146.0K | +7% | +$8,137 |
| D | 2024-11-12 | 2024-11-11 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -5,026 | 141.0K | -3% | -$75.4K |
| D | 2024-11-08 | 2024-11-06 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +25.5K | 161.5K | +19% | +$27.5K |
| D | 2024-11-08 | 2024-11-06 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.03 | -25.5K | 136.0K | -16% | -$383.0K |
| DM | 2024-10-15 | 2024-10-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8187 | +10.4K | 130.6K | +9% | +$8,489 |
| 2024-10-15 | 2024-10-11 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $13.52 | -15.3K | 895.9K | -2% | -$206.5K | |
| 2024-10-15 | 2024-10-11 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $13.57 | -10.8K | 236.9K | -4% | -$146.0K | |
| DM | 2024-09-12 | 2024-09-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 125.6K | +10% | +$9,567 |
| DM | 2024-08-13 | 2024-08-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 114.2K | +11% | +$9,565 |
| I | 2024-07-26 | 2024-07-24 | MLYS | Slingsby Brian Taylor | Dir, 10% | S - Sale | $13.05 | -550.0K | 8.64M | -6% | -$7.18M |
| D | 2024-07-18 | 2024-07-16 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +525 | 103.4K | +0.5% | +$567 |
| D | 2024-07-18 | 2024-07-16 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -525 | 102.9K | -0.5% | -$7,875 |
| 2024-07-12 | 2024-07-11 | MLYS | Congleton Jon | CEO, Dir | S - Sale | $13.34 | -15.7K | 911.2K | -2% | -$210.1K | |
| DM | 2024-07-12 | 2024-07-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 102.9K | +12% | +$9,566 |
| 2024-07-12 | 2024-07-11 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $13.14 | -10.8K | 247.6K | -4% | -$141.3K | |
| M | 2024-06-20 | 2024-06-17+ | MLYS | Congleton Jon | CEO, Dir | S - Sale | $12.00 | -49.3K | 927.0K | -5% | -$592.0K |
| M | 2024-06-14 | 2024-06-12+ | MLYS | Congleton Jon | CEO, Dir | S - Sale | $12.70 | -72.8K | 976.3K | -7% | -$924.4K |
| DM | 2024-06-13 | 2024-06-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 89.7K | +15% | +$9,566 |
| 2024-06-13 | 2024-06-11 | MLYS | Levy Adam Scott | CFO, Sec | S - Sale | $12.94 | -96.8K | 255.5K | -27% | -$1.25M | |
| DM | 2024-05-15 | 2024-05-13 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 78.4K | +17% | +$9,566 |
| D | 2024-05-10 | 2024-05-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +100 | 67.1K | +0.1% | +$108 |
| D | 2024-05-10 | 2024-05-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -100 | 67.0K | -0.1% | -$1,500 |
| DM | 2024-04-15 | 2024-04-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 67.0K | +20% | +$9,566 |
| DM | 2024-03-13 | 2024-03-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 55.6K | +26% | +$9,565 |
| DI | 2024-02-14 | 2024-02-12 | MLYS | RA CAPITAL MANAGEMENT, L.P. | Dir | A - Grant | $13.50 | +1.67M | 2.98M | +128% | +$22.58M |
| I | 2024-02-14 | 2024-02-12 | MLYS | AKKARAJU SRINIVAS | Dir, 10% | A - Grant | $13.50 | +555.6K | 5.07M | +12% | +$7.50M |
| I | 2024-02-14 | 2024-02-12 | MLYS | Samsara BioCapital, L.P. | 10% | P - Purchase | $13.50 | +555.6K | 5.07M | +12% | +$7.50M |
| DM | 2024-02-13 | 2024-02-12 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 37.9K | +43% | +$9,566 |
| DM | 2024-01-12 | 2024-01-11+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 32.9K | +53% | +$9,565 |
| D | 2023-12-12 | 2023-12-11 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +5,018 | 20.1K | +33% | +$2,710 |
| 2023-11-27 | 2023-11-22 | MLYS | Congleton Jon | CEO, Dir | P - Purchase | $5.97 | +4,250 | 1.05M | +0.4% | +$25.4K | |
| D | 2023-11-14 | 2023-11-13 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +5,017 | 15.1K | +50% | +$2,709 |
| D | 2023-11-07 | 2023-11-03 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +10.0K | 10.0K | New | +$5,418 |
| 2023-09-08 | 2023-09-06 | MLYS | Congleton Jon | CEO, Dir | P - Purchase | $12.08 | +2,250 | 1.04M | +0.2% | +$27.2K | |
| 2023-08-21 | 2023-08-17 | MLYS | Congleton Jon | CEO, Dir | P - Purchase | $12.10 | +2,250 | 1.04M | +0.2% | +$27.2K | |
| 2023-08-11 | 2023-08-11 | MLYS | Congleton Jon | CEO, Dir | P - Purchase | $12.89 | +2,000 | 1.04M | +0.2% | +$25.8K | |
| DM | 2023-08-11 | 2023-08-10+ | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.7175 | +231.7K | 76.2K | New | +$166.3K |
| DM | 2023-08-11 | 2023-08-10+ | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $12.92 | -231.7K | 0 | -100% | -$2.99M |
| DI | 2023-02-16 | 2023-02-14 | MLYS | Slingsby Brian Taylor | Dir, 10% | P - Purchase | $16.00 | +250.0K | 9.19M | +3% | +$4.00M |
| DI | 2023-02-16 | 2023-02-14 | MLYS | Slingsby Brian Taylor | Dir, 10% | C - Cnv Deriv | — | +4.31M | 8.94M | +93% | — |
| DM | 2023-02-16 | 2023-02-14 | MLYS | HBM Healthcare Investments (Cayman) Ltd. | 10% | C - Cnv Deriv | — | +2.91M | 1.94M | New | — |
| D | 2023-02-16 | 2023-02-14 | MLYS | HBM Healthcare Investments (Cayman) Ltd. | 10% | P - Purchase | $16.00 | +312.5K | 3.22M | +11% | +$5.00M |
| DI | 2023-02-16 | 2023-02-14 | MLYS | AKKARAJU SRINIVAS | Dir, 10% | C - Cnv Deriv | — | +3.58M | 3.58M | New | — |
| DI | 2023-02-16 | 2023-02-14 | MLYS | AKKARAJU SRINIVAS | Dir, 10% | P - Purchase | $16.00 | +937.5K | 4.52M | +26% | +$15.00M |
| 2023-02-16 | 2023-02-14 | MLYS | Levy Adam Scott | CFO, Chief Bus. Off, Secy | P - Purchase | $16.00 | +6,250 | 350.8K | +2% | +$100.0K | |
| DMI | 2023-02-16 | 2023-02-14 | MLYS | RA Capital Nexus Fund III, L.P. | Dir | P - Purchase | $16.00 | +1.25M | 1.31M | +2,041% | +$20.00M |
| DMI | 2023-02-16 | 2023-02-14 | MLYS | RA Capital Nexus Fund III, L.P. | Dir | C - Cnv Deriv | — | +1.93M | 192.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations